Foreclosures | Mortgages | Financing
While the Consumer Financial Protection Bureau is fighting to uphold its authority in a federal court, the governmental agency which so often finds itself in the crosshairs of legislators and the financial industry, has a new enemy in the form of the Wall Street Journal’s editorial board, which authored a scathing takedown of the CFPB, questioning whether the agency is operating outside of the parameters of the Constitution. …read more
From:: Real Estate Wire
Millennials planning to buy a home outweigh those who are financially able to buy a home, however all hope is not lost. The senior vice president of TransUnion gives some tips to Millennials looking at entering the housing market. …read more
From:: Real Estate Wire
Millennials planning to buy a home outweigh those who are financially able to buy a home, however all hope is not lost. The senior vice president of TransUnion gives some tips to Millennials looking at entering the housing market. …read more
From:: Real Estate Wire
Less than two weeks after the Federal Housing Finance Agency announced that Fannie Mae and Freddie Mac will be reducing the principal on as many as 33,000 delinquent or underwater borrowers, Fannie Mae announced it now plans to begin securitizing loans that were once delinquent. …read more
From:: Real Estate Wire
United Technologies Corp. late Monday said its board hiked the company’s dividend by 3%. The new 66-cents-a-share dividend is payable June 10 to shareholders of record as of May 20. United Technologies shares were flat at $105.20 after hours.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News
Aratana Therapeutics Inc. shares rallied in the extended session Monday after the animal-drug maker said it entered a licensing agreement with Eli Lilly & Co’s Elanco animal health unit. Aratana shares surged 19% to $8.23 after hours. The company said Elanco is paying the company $45 million upfront for a collaboration, licensing, and development agreement connected to the company’s Galliprant dog osteoarthritis treatment. Aratana said the agreement also comes with a $75 million payment if certain sales milestones are met, as well as royalty payments from Elanco.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News
Aratana Therapeutics Inc. shares rallied in the extended session Monday after the animal-drug maker said it entered a licensing agreement with Eli Lilly & Co’s Elanco animal health unit. Aratana shares surged 19% to $8.23 after hours. The company said Elanco is paying the company $45 million upfront for a collaboration, licensing, and development agreement connected to the company’s Galliprant dog osteoarthritis treatment. Aratana said the agreement also comes with a $75 million payment if certain sales milestones are met, as well as royalty payments from Elanco.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News
Aratana Therapeutics Inc. shares rallied in the extended session Monday after the animal-drug maker said it entered a licensing agreement with Eli Lilly & Co’s Elanco animal health unit. Aratana shares surged 19% to $8.23 after hours. The company said Elanco is paying the company $45 million upfront for a collaboration, licensing, and development agreement connected to the company’s Galliprant dog osteoarthritis treatment. Aratana said the agreement also comes with a $75 million payment if certain sales milestones are met, as well as royalty payments from Elanco.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News
Sanmina Corp. stock pushed higher by 7% in late trading Monday after the contract tech manufacturer showed off higher profits than expected. Sanmina’s earnings report showed profit of $30.36 million, or 39 cents a share, on sales of $1.61 billion; after adjustments for stock-based compensation and other factors, the company said it earned 63 cents per share. Analysts on average expected adjusted earnings of 56 cents a share on sales of $1.59 billion, according to FactSet, and Sanmina had predicted adjusted profit in a range of 55 cents to 59 cents a share. Sanmina Chief Executive Jure Sola noted that Sanmina had its highest earnings per share in more than a decade thanks to growth across market segments. “As we further diversify our business, we remain confident our financial results will continue to improve,” Sola said in Monday’s announcement.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News
Container Store Group Inc. shares rallied in the extended session Monday after the storage and organization products retailer’s earnings outlook topped Wall Street estimates. Container Store shares jumped 22% to $7.10 after hours. The company forecast fiscal 2016 earnings of 20 cents to 30 cents a share on revenue of $830 million to $845 million. Analysts surveyed by FactSet had estimated earnings of 20 cents a share on revenue of $861.4 million. For the fiscal fourth quarter, Container Store reported earnings of 20 cents a share on revenue of $232.1 million. Analysts had forecast earnings of 20 cents a share on revenue of $230.8 million.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News